Viewing nowDonepezil Tablets 10 mg (Donepezil Hydrochloride)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

MFDS item code 201406044 · Approved 2014.12.24 · Insurance code 622802260
Treatment of symptoms of Alzheimer's-type dementia
This medication is used to improve symptoms such as memory decline and cognitive dysfunction in Alzheimer's dementia. It helps reduce difficulties experienced in daily life and enhances the overall quality of life of patients.
Adults: Administer 5 mg of donepezil hydrochloride once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, consider taking this medicine in the morning. Since donepezil reaches steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg per day, administer with attention to gastrointestinal adverse reactions. If this medicine is discontinued, its effects gradually decrease, and no rebound effect occurs with abrupt discontinuation. Women aged 85 years or older with low body weight: Careful monitoring is necessary because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg per day.
Children: There is no experience with use in children.
This medication contains Donepezil Hydrochloride as its active ingredient and is primarily used to treat symptoms of Alzheimer's dementia. This medication should not be used in certain patients, such as those who are allergic to this drug or similar components, pregnant or breastfeeding women, and patients with lactose intolerance or specific genetic metabolic disorders. Patients with heart disease or conduction disorders should use this medication with caution as it may slow heart rate and cause arrhythmias. Additionally, patients with a history of peptic ulcers or those taking non-steroidal anti-inflammatory drugs should be carefully administered due to the risk of gastrointestinal bleeding. Patients with asthma or obstructive pulmonary disease should be cautious as this medication can increase bronchial contraction and mucus secretion, worsening symptoms. Patients with extrapyramidal disorders such as Parkinson's disease should also be careful as this medication may exacerbate symptoms. This medication contains a colorant called Tartrazine (Yellow No. 5), and those allergic to this component must inform before use. During the use of this medication, adverse cardiac reactions such as fainting, bradycardia, heart block, myocardial infarction, and heart failure may occur, and any symptoms should be immediately discussed with healthcare providers. Serious adverse reactions such as gastrointestinal bleeding, liver dysfunction, cerebral hemorrhage, seizures, movement disorders, neuroleptic malignant syndrome, rhabdomyolysis, respiratory distress, acute pancreatitis, acute renal failure, and unexplained sudden death may also occur rarely. Additionally, various side effects have been reported, including nausea, vomiting, diarrhea, loss of appetite, dizziness, insomnia, hallucinations, aggressive behavior, anxiety, drowsiness, headache, fatigue, rash, myalgia, and urinary incontinence, so any unusual symptoms should be reported to healthcare providers. This medication is not approved for use in other types of dementia or memory disorders besides Alzheimer's dementia, and treatment should be conducted under the supervision of an experienced physician. The therapeutic effects should be regularly evaluated, and if ineffective, consideration should be given to discontinuing the medication. Patients with heart disease or electrolyte abnormalities, particularly those with QT interval prolongation or taking medications that affect the QT interval, require cardiac monitoring. This medication may exacerbate peptic ulcers by promoting gastrointestinal motility and gastric acid secretion, so patients with a history of gastrointestinal diseases should be careful. It may affect the ability to drive or operate machinery, so caution is advised at the beginning of treatment or when increasing the dosage. Pregnant or breastfeeding women should not use this medication; if absolutely necessary, a careful decision should be made after consulting a specialist. This medication may interact with other drugs, particularly those that affect CYP3A4 and CYP2D6 enzymes, so caution is required when used concomitantly. Additionally, caution is necessary when combined with drugs affecting cardiac conduction, cholinergic agents, anticholinergic medications, and non-steroidal anti-inflammatory drugs. In case of overdose, severe symptoms such as nausea, vomiting, bradycardia, hypotension, respiratory depression, and seizures may occur, requiring immediate emergency treatment, and atropine can be used as an antidote. This medication should be stored out of reach of children, and transferring to another container is not recommended as it may negatively affect the quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture infiltration. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the medication's effectiveness for an extended period.
Yellow round film-coated tablets
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.